Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial (NCT01003496) | Clinical Trial Compass
CompletedPhase 3
Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial
United States204 participantsStarted 2009-11-05
Plain-language summary
The purpose of this 2 year study is to conduct a fully powered effectiveness trial comparing recovery trajectories of 200 drug dependent adults (the subjects) who will be randomly assigned to Treatment as Usual (TAU) or TAU + Long-Term Recovery Management (LTRM).
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
To be eligible for the study, a subject must:
* At least 18 years of age
* Meet current dependence criteria for stimulants (cocaine/other), opioids (heroin/other), and/or alcohol (if also dependent on cocaine or opioids). Persons who are opioid dependent are eligible if they are not in methadone maintenance therapy; they will be eligible if they are in short-term buprenorphine detoxification
* Self-report use of a primary drug of dependence in the past 60 days; 4) be admitted to outpatient care at Maryhaven
* Willing to participate in the protocol (i.e., to be randomized to treatment condition and agree to attend regular treatment sessions).
Exclusion Criteria:
* Potential subjects will be excluded if they: 1) present with current suicide risk
* Have a current, untreated psychotic disorder
* Plan to relocate outside of the area within 12 months
* Have been sentenced to incarceration of more than 30 days over the next 6 months
* Are alcohol dependent without current dependence on cocaine or opioids.
What they're measuring
1
The main outcome is weeks of abstinence from the primary drug of dependence.